(Q44451422)

3 December 2017

title

Clobazam monotherapy in drug naïve adult patients with epilepsy (English)

1 reference

3 December 2017

M M Mehndiratta

1

1 reference

3 December 2017

M Krishnamurthy

series ordinal

2

1 reference

3 December 2017

K N Rajesh

series ordinal

3

1 reference

3 December 2017

Gurubax Singh

series ordinal

4

1 reference

3 December 2017

publication date

1 June 2003

1 reference

Seizure-European Journal of Epilepsy

3 December 2017

published in

1 reference

3 December 2017

volume

12

1 reference

3 December 2017

issue

4

1 reference

3 December 2017

page(s)

226-228

1 reference

Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2802%2900263-7

7 January 2021

Clobazam in Treatment of Refractory Epilepsy: The Canadian Experience. A Retrospecti

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2802%2900263-7

7 January 2021

Clobazam has equivalent efficacy to carbamazepine and phenytoin as monotherapy for childhood epilepsy. Canadian Study Group for Childhood Epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2802%2900263-7

7 January 2021

Pharmacology of anti-anxiety drugs with special reference to clobazam

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2802%2900263-7

7 January 2021

Clobazam in Long‐Term Epilepsy Treatment: Sustained Responders Versus Those Developing Tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2802%2900263-7

7 January 2021

Lamotrigine monotherapy in newly diagnosed untreated epilepsy: a double-blind comparison with phenytoin

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2802%2900263-7

7 January 2021

Topiramate monotherapy for partial onset seizures.

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2802%2900263-7

7 January 2021

10.1016/S1059-1311(02)00263-7

Identifiers

DOI

1 reference

3 December 2017

1 reference